Moreover, given that the role of miRNAs in the fine-tuning of EMT/MET dynamics is not limited to the hepatocytes (e.g., miR-200 family regulation is involved in the progression of different epithelial tumors, including breast and colorectal cancer [46,61,62]), the impact of SYNCRIP in their regulation could also have relevance in other cell types. This evidence concerns the gene SYNCRIP and colorectal cancer.